|
Cannabis Campaigners' Guide News Database result:
|
|
UK: Cannabis spray imports boost for GW
Richard Irving The Times
Wednesday 16 Nov 2005 GW PHARMACEUTICALS, the fledgeling biotech company announced its third piece of good news in a week yesterday when Britain's Drugs Minister confirmed that UK patients could legally import a cannabis-based medicine developed by its scientists. Shares in the company jumped 18 per cent to 83p after it said that the Home Office had agreed to requests from doctors and patients to allow imports of Sativex from Canada, where the drug has been on sale since June. GW believes that Sativex, an under-the-tongue spray, can help to relieve symptoms associated with multiple sclerosis (MS), including pain in the nerve endings, muscle spasms and even sleep deprivation. The company said that Paul Goggins, the Drugs Minister, had confirmed that the cannabis-based treatment could be "prescribed and supplied in response to an unsolicited request to fulfil the special needs of an individual." GW has been waging an uphill battle to convince UK drug regulators to approve the medicine for several years. This year the authorities ordered the company to run new trials to prove conclusively that the drug alleviates MS symptoms. Last week health officials in Catalonia approved the treatment, while scientists published research to suggest that it might offer relief to patients with rheumatoid arthritis.
After you have finished reading this article you can click here to go back.
|
This page was created by the Cannabis Campaigners' Guide.
Feel free to link to this page!